
ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease
Keywords: Alzheimer disease; Aβ25-35; HPA axis; Glibenclamide; ATP-sensitive potassium channel;